Related Experiment Video
Updated: Sep 23, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Circular RNA_0120376 regulates microRNA-148b-3 and centrosomal protein 55 to promote non-small cell lung cancer
Tiantian Du1, Shenni Yi1, Yuanyuan Wang1
1Department of Respiratory and Critical Medicine, Yantai Yuhuangding Hospital, Yantai, China.
Abstract:
Circular RNAs (circRNAs) are non-coding RNAs with covalent closed-loop structures that are vital in regulating diverse pathological processes. This work is aimed to investigate the role of circ_0120376 in non-small cell lung cancer (NSCLC). Circ_0120376, microRNA (miR)-148b-3p, and centrosomal protein 55 (CEP55) mRNA expression in NSCLC tissues and cells were determined using qRT-PCR. The influences of circ_0120376 and miR-148b-3p on the proliferation of NSCLC cell lines were analyzed by CCK-8 and colony formation assays. Apoptosis was analyzed by flow cytometry. Cell migration and invasion were analyzed using the Transwell experiment. Binding relationships between circ_0120376 and miR-148b-3p and between miR-148b-3p and CEP55 3'UTR were investigated using the dual-luciferase reporter experiment and the RIP experiment. Western blot was conducted to analyze the regulatory effect of circ_0120376 and miR-148b-3p on CEP55 expression. We found that circ_0120376 was markedly overexpressed in NSCLC, and its overexpression was positively associated with increased T stage and lymph node metastasis of the patients. Functional experiments unveiled that circ_0120376 enhanced the proliferation, migration and invasion of NSCLC cells and impeded apoptosis, while knocking down circ_0120376 remarkably suppressed the malignant features of NSCLC cells mentioned above. Circ_0120376 could adsorb miR-148b-3p to reduce miR-148b-3p expression, and circ_0120376 could increase CEP55 expression via adsorbing miR-148b-3p. In summary, circ_0120376 contributes to the malignancy of NSCLC cells through a ceRNA mechanism via regulating miR-148b-3p/CEP55 axis. Circ_0120376 is likely to be a potential diagnostic biomarker and therapeutic target for NSCLC.
Insights
Circular RNAs (circRNAs) promote non-small cell lung cancer (NSCLC) malignancy by upregulating CEP55 via sponging miR-148b-3p. Circ_0120376 may serve as a diagnostic biomarker and therapeutic target for NSCLC patients.
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- Circular RNAs (circRNAs) are key regulators in biological processes.
- Dysregulation of circRNAs is implicated in various cancers, including NSCLC.
- The specific role of circ_0120376 in NSCLC remains largely unexplored.
Purpose of the Study:
- To investigate the role and mechanism of circ_0120376 in non-small cell lung cancer (NSCLC).
- To explore the potential of circ_0120376 as a diagnostic biomarker and therapeutic target for NSCLC.
Main Methods:
- qRT-PCR to quantify circ_0120376, miR-148b-3p, and CEP55 mRNA expression.
- Cell proliferation, apoptosis, migration, and invasion assays (CCK-8, colony formation, flow cytometry, Transwell).
- Dual-luciferase reporter and RIP assays to confirm molecular interactions.
- Western blot to assess protein expression levels.
Main Results:
- Circ_0120376 was significantly overexpressed in NSCLC tissues and correlated with advanced T stage and lymph node metastasis.
- Overexpression of circ_0120376 promoted NSCLC cell proliferation, migration, and invasion while inhibiting apoptosis.
- Circ_0120376 acted as a molecular sponge for miR-148b-3p, thereby increasing CEP55 expression.
- Knockdown of circ_0120376 suppressed NSCLC cell malignancy.
Conclusions:
- Circ_0120376 promotes NSCLC progression through the ceRNA mechanism by regulating the miR-148b-3p/CEP55 axis.
- Circ_0120376 presents a potential diagnostic biomarker and therapeutic target for NSCLC.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
piRNA - Piwi-interacting RNAs
The Nucleolus
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

